Hiroaki Nozaki

2.2k total citations
38 papers, 914 citations indexed

About

Hiroaki Nozaki is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Hiroaki Nozaki has authored 38 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 17 papers in Molecular Biology and 14 papers in Neurology. Recurrent topics in Hiroaki Nozaki's work include Cerebrovascular and genetic disorders (18 papers), Neurological Disease Mechanisms and Treatments (7 papers) and Moyamoya disease diagnosis and treatment (6 papers). Hiroaki Nozaki is often cited by papers focused on Cerebrovascular and genetic disorders (18 papers), Neurological Disease Mechanisms and Treatments (7 papers) and Moyamoya disease diagnosis and treatment (6 papers). Hiroaki Nozaki collaborates with scholars based in Japan, United States and Malaysia. Hiroaki Nozaki's co-authors include Osamu Onodera, Masatoyo Nishizawa, Takeshi Ikeuchi, Takuya Konno, Atsushi Shiga, Shu‐ichi Ikeda, Toshiki Mizuno, Taisuke Kato, Hitoshi Takahashi and Yasuko Toyoshima and has published in prestigious journals such as Journal of Neuroscience, Neurology and Stroke.

In The Last Decade

Hiroaki Nozaki

34 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Nozaki Japan 17 429 421 394 182 170 38 914
Takuya Konno Japan 18 569 1.3× 416 1.0× 478 1.2× 281 1.5× 157 0.9× 44 1.1k
Robert G. Farrer United States 13 334 0.8× 386 0.9× 117 0.3× 92 0.5× 285 1.7× 26 947
Zhixiang Liao United States 8 405 0.9× 546 1.3× 96 0.2× 153 0.8× 246 1.4× 13 968
Alejandro D. Roth Chile 13 148 0.3× 319 0.8× 187 0.5× 110 0.6× 229 1.3× 22 859
Catherine Strand United Kingdom 18 706 1.6× 251 0.6× 293 0.7× 524 2.9× 303 1.8× 22 1.3k
Serena Ghezzi Italy 17 272 0.6× 470 1.1× 195 0.5× 135 0.7× 205 1.2× 33 944
K. Arima Japan 18 600 1.4× 419 1.0× 353 0.9× 452 2.5× 350 2.1× 31 1.2k
Emiko Morimoto Japan 11 214 0.5× 201 0.5× 426 1.1× 150 0.8× 116 0.7× 20 860
Kenji Jinnai Japan 19 394 0.9× 507 1.2× 170 0.4× 128 0.7× 487 2.9× 65 1.0k
Coro Paisán‐Ruiz United States 19 472 1.1× 479 1.1× 291 0.7× 166 0.9× 322 1.9× 34 1.1k

Countries citing papers authored by Hiroaki Nozaki

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Nozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nozaki more than expected).

Fields of papers citing papers by Hiroaki Nozaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Nozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nozaki. The network helps show where Hiroaki Nozaki may publish in the future.

Co-authorship network of co-authors of Hiroaki Nozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nozaki. A scholar is included among the top collaborators of Hiroaki Nozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nozaki. Hiroaki Nozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uemura, Masahiro, et al.. (2022). Patients with heterozygous HTRA1-related cerebral small vessel disease misdiagnosed with other diseases: Two case reports. Clinical Neurology and Neurosurgery. 223. 107502–107502. 4 indexed citations
2.
Uemura, Masahiro, Hiroaki Nozaki, Akihide Koyama, et al.. (2019). HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade. Frontiers in Neurology. 10. 693–693. 17 indexed citations
3.
Morita, Takashi, Noriko Saito, Hisaki Shimada, et al.. (2018). Renal histopathological findings of retinal vasculopathy with cerebral leukodystrophy. CEN Case Reports. 7(1). 83–89. 2 indexed citations
4.
Saito, Natsumi, Tomohiko Ishihara, Kensaku Kasuga, et al.. (2018). Case Report: A patient with spinocerebellar ataxia type 31 and sporadic Creutzfeldt-Jakob disease. Prion. 12(2). 147–149. 1 indexed citations
5.
Nozaki, Hiroaki, et al.. (2017). A CARASIL Patient from Americas with Novel Mutation and Atypical Features: Case Presentation and Literature Review. Cerebrovascular Diseases. 44(3-4). 135–140. 13 indexed citations
6.
Miura, Takeshi, Kotaro Ogaki, Makoto Eriguchi, et al.. (2017). LMNB1-related autosomal dominant leukodystrophy: genetic and clinical studies of three Japanese families (P1.088). Neurology. 88(16_supplement).
7.
Konno, Takuya, Daniel F. Broderick, Daita Kaneda, et al.. (2016). Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia. American Journal of Neuroradiology. 38(1). 77–83. 39 indexed citations
8.
Takeuchi, Ryoko, Mari Tada, Atsushi Shiga, et al.. (2016). Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes. Acta Neuropathologica Communications. 4(1). 61–61. 39 indexed citations
9.
Nozaki, Hiroaki, Yumi Sekine, Toshio Fukutake, et al.. (2015). Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology. 85(5). 459–463. 48 indexed citations
10.
Shimohata, Takayoshi, et al.. (2014). Disease notification and self-determination in treatment decisions for patients with Creutzfeldt-Jakob disease. Rinsho Shinkeigaku. 54(4). 298–302.
11.
Nozaki, Hiroaki. (2012). Consideration of the pathogenesis of CARASIL. Rinsho Shinkeigaku. 52(11). 1360–1362. 1 indexed citations
12.
Konno, Takuya, et al.. (2011). A case of CADASIL without characteristic anterior temporal pole lesion diagnosed by skin biopsy. Rinsho Shinkeigaku. 51(10). 770–773. 2 indexed citations
13.
Shiga, Atsushi, Hiroaki Nozaki, Akio Yokoseki, et al.. (2011). Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1. Human Molecular Genetics. 20(9). 1800–1810. 89 indexed citations
14.
Yamazaki, Haruka, Hiroaki Nozaki, Osamu Onodera, et al.. (2011). Functional characterization of the P1059L mutation in the inositol 1,4,5-trisphosphate receptor type 1 identified in a Japanese SCA15 family. Biochemical and Biophysical Research Communications. 410(4). 754–758. 23 indexed citations
15.
Ikeuchi, Takeshi, Ryoko Koike, Hiroaki Nozaki, et al.. (2010). Long‐term disability and prognosis in dentatorubral‐pallidoluysian atrophy: A correlation with CAG repeat length. Movement Disorders. 25(11). 1694–1700. 21 indexed citations
16.
Ikeuchi, Takeshi, Hiroyuki Kaneko, Akinori Miyashita, et al.. (2008). Mutational Analysis in Early-Onset Familial Dementia in the Japanese Population. Dementia and Geriatric Cognitive Disorders. 26(1). 43–49. 49 indexed citations
17.
Nozaki, Hiroaki, Takayoshi Shimohata, Takashi Kanbayashi, et al.. (2008). A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Medicine. 10(2). 253–255. 26 indexed citations
18.
Nozaki, Hiroaki, Takeshi Ikeuchi, Akio Kawakami, et al.. (2007). Clinical and genetic characterizations of 16q‐linked autosomal dominant spinocerebellar ataxia (AD‐SCA) and frequency analysis of AD‐SCA in the Japanese population. Movement Disorders. 22(6). 857–862. 26 indexed citations
20.
Kawato, Takayuki, et al.. (1999). Evaluation of human tooth structure with the ultrasonic imaging technique.. Journal of Oral Science. 41(4). 191–197. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026